Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/122071
Campo DC Valoridioma
dc.contributor.authorVallejo Torres, Lauraen_US
dc.date.accessioned2023-04-26T09:32:18Z-
dc.date.available2023-04-26T09:32:18Z-
dc.date.issued2023en_US
dc.identifier.issn1175-5652en_US
dc.identifier.otherScopus-
dc.identifier.urihttp://hdl.handle.net/10553/122071-
dc.description.abstractBackground: The traditional cost-effectiveness analysis framework usually takes a healthcare system perspective, where the aim is to maximise population health from a fixed budget allocated to healthcare. Extensions to this framework have been suggested, including: (i) incorporating impacts that fall outside the healthcare sector; (ii) accounting for outcomes beyond health; and (iii) assessing equity considerations. Several alternatives have been proposed that serve these purposes, for example, the extended “impact inventory”, the “beyond-the-QALY” approach and the distributional cost-effectiveness analysis. Objective: This paper aims to develop a comprehensive framework that incorporates into the cost-effectiveness analysis framework some of its most advocated extensions and provides a means of arriving at a unidimensional cost-effectiveness analysis result measure. Methods: Building on previous work, I proposed a framework that explicitly incorporates the full extent of the opportunity costs that arise when new dimensions and distributional concerns are included in cost-effectiveness analyses. A hypothetical example is provided as a way of illustration. Results: Operationalising the proposed framework requires system-wide representative values and/or robust estimates concerning: (i) selecting dimensions; (ii) measuring opportunity costs associated with each dimension; (iii) quantifying equity weights and percentages of beneficiaries and losers meeting equity considerations; and (iv) attaching monetary values to dimensions measured using a non-monetary metric. Conclusions: Extending the cost-effectiveness analysis framework entails extending the measurement of the opportunity costs of funding decisions. This implies populating an ambitious puzzle that in some cases poses fundamental conceptual and empirical questions. Potential routes of further research that might facilitate such undertaking are proposed.en_US
dc.languageengen_US
dc.relation.ispartofApplied Health Economics and Health Policyen_US
dc.sourceApplied Health Economics and Health Policy [ISSN 1175-5652], (Enero 2023)en_US
dc.subject5311 Organización y dirección de empresasen_US
dc.subject.otherAnálisis coste beneficioen_US
dc.titleThe broader opportunity costs in the broader cost-effectiveness analysis frameworken_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s40258-023-00801-zen_US
dc.identifier.scopus85152394724-
dc.contributor.orcid0000-0001-5833-6066-
dc.contributor.authorscopusid56309858100-
dc.identifier.eissn1179-1896-
dc.investigacionCiencias Sociales y Jurídicasen_US
dc.type2Artículoen_US
dc.utils.revisionen_US
dc.date.coverdateEnero 2023en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-ECOen_US
dc.description.sjr0,99
dc.description.jcr3,1
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
dc.description.ssciSSCI
dc.description.miaricds10,8
item.fulltextCon texto completo-
item.grantfulltextopen-
crisitem.author.deptGIR Economía de la salud y políticas públicas-
crisitem.author.deptDepartamento de Métodos Cuantitativos en Economía y Gestión-
crisitem.author.orcid0000-0001-5833-6066-
crisitem.author.parentorgDepartamento de Métodos Cuantitativos en Economía y Gestión-
crisitem.author.fullNameVallejo Torres, Laura-
Colección:Artículos
Adobe PDF (859,97 kB)
Vista resumida

Citas SCOPUSTM   

7
actualizado el 30-mar-2025

Citas de WEB OF SCIENCETM
Citations

7
actualizado el 30-mar-2025

Visitas

74
actualizado el 07-sep-2024

Descargas

24
actualizado el 07-sep-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.